Added 4 days ago Drug news
Results of Phase III trials NORTHSTAR-2 and NORTHSTAR-3 of LentiGlobin gene therapy to treat transfusion-dependent beta-thalassemia. bluebirdbio.
bluebird bio, Inc. announced new data from the Phase III Northstar-2 (HGB-207) and Northstar-3 (HGB-212) clinical studies of its investigational...
Added 6 days ago Drug news
Positive results from BELIEVE study of luspatercept for the treatment of adults with beta-thalassemia-associated anemia. Celgene + Acceleron.
Celgene Corporation and Acceleron Pharma Inc.announced results from a pivotal, phase III trial (BELIEVE) evaluating the safety and efficacy of...
Added 21 days ago Drug news
FDA approves expended label for Promacta to include first-line treatment for adults and pediatric patients two years and older with severe aplastic anemia.-Novartis
Novartis announced that the FDA has expanded the label for Promacta (eltrombopag) to include first-line treatment for adults and pediatric...
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
Experts discuss the use of non-vitamin K oral anticoagulants in the treatment and prevention of stroke, deep vein thrombosis and pulmonary embolism in atrial fibrillation patients.
See information on best practice in solid organ transplantation, and expert discussions on related hot topics.
The Atopic Dermatitis Knowledge Centre is an educational resource, intended for healthcare professionals, that provides credible medical information on the epidemiology, pathophysiology and burden of atopic dermatitis, as well as diagnostic techniques, treatment regimens and guideline recommendations.
Discover an overview of hypophosphatasia and details required to facilitate the timely and accurate detection of low alkaline phosphatase.
EADV Congress 2018: Bringing you the latest news and insights from 27th EADV Congress, 12-16 September 2018 Paris, France.
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines
Anaemia and iron deficiency are frequent complications in patients with solid tumours or haematological malignancies, particularly in patients treated with chemotherapeutic agents.
Added 7 months ago
This is a comprehensive but pragmatic new guideline and focuses on the accurate diagnosis, delineation of severity types and subsequent management of this rare haematological condition.
Added 3 years ago
The objective of this guideline is to provide healthcare professionals with guidance on the management of patients with primary autoimmune haemolytic anaemia (AIHA).
Added 8 months ago
Our meta-analysis published in 2010 provided evidence that low levels of serum albumin (hypoalbuminemia) are a significant independent predictor of acute kidney injury (AKI) and death following AKI.
Added 1 year ago
Could testosterone therapy in hypogonadal men ameliorate anemia, a cardiovascular risk factor? An observational, 54-week cumulative registry study.
In this study we investigated if testosterone undecanoate attenuates anemia and the risk of cardiovascular disease in patients with hypogonadism.
Added 1 year ago
Hemolytic-uremic syndrome (HUS) is the triad of microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and acute kidney injury (AKI); the main cause of multi-organ failure is related to thrombotic microangiopathy (TMA).
Added 1 year ago
An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia (BELIEVE)
This is a Phase 3, double-blind, randomized, placebo-controlled, multicenter study to determine the efficacy and safety of luspatercept (ACE-536) plus Best supportive care (BSC) versus placebo plus BSC in...
Added 4 months ago
A Study Evaluating the Efficacy and Safety of LentiGlobin BB305 Drug Product in Beta-Thalassemia Major and Sickle Cell Disease
This is a Phase 1/2, open label, safety, and efficacy study of the administration of LentiGlobin BB305 Drug Product to subjects with either beta-thalassemia major or severe sickle cell disease (SCD).
Added 5 years ago
- Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
- Credits available
- Registration required
- Subscription fee